Remove world asia-pacific
article thumbnail

Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific

Pharma Mirror

New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. The post Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific appeared first on Pharma Mirror Magazine.

52
article thumbnail

Thermo Fisher Scientific opens sterile drug facility in Singapore

Pharmaceutical Technology

Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Asia-Pacific Regulatory & Industry Views on Drug Shortage Prevention

ISPE

The webinar was moderated by Vivien Santillan, Regional Director, Asia, Novatek International. Regulatory speakers were Lisa Hedman, Group Lead for the Division of Supply and Access to Medicines of the World Health Organization (WHO); and Joyce Cirunay, Director IV of the Center for Drug Regulation and Research at the Philippines FDA.

article thumbnail

Alzheimer’s therapeutics market to reach $6.8 billion by 2032

European Pharmaceutical Review

The research segmented the market regionally as North America, Europe, Asia Pacific, Latin America, Middle East & Africa and the Rest of the World. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific region. percent in Central Europe to 8.7

article thumbnail

Pharma contract manufacturing market to grow to $130bn by 2026

European Pharmaceutical Review

Based on region, China, the world`s second largest economy, is forecast to reach a projected market size of $21.1 Lower labour costs, presence of significant talent pool and growing domestic markets are some of the factors driving growth in the Asia-Pacific region. Within the $130.2 billion, growing at a CAGR of 4.4 percent, 4.1

article thumbnail

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Pharma Mirror

According to the Endpoints ASCO session: “China and the US are the world’s largest oncology research destinations, and the. The post Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China appeared first on Pharma Mirror Magazine.

52
article thumbnail

Country focus: China & APAC’s growing medical needs bring opportunities and challenges

pharmaphorum

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. Home to over 60% of the world’s population, Asia Pacific (APAC) is not a region the biopharma industry can afford to ignore.